Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.994 SEK | +2.26% | +1.95% | +44.27% |
Sales 2024 * | 266M 24.89M | Sales 2025 * | 136M 12.69M | Capitalization | 640M 59.81M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | -72M -6.73M | EV / Sales 2024 * | 1.29 x |
Net cash position 2024 * | 297M 27.77M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.71 x |
P/E ratio 2024 * |
-1.82
x | P/E ratio 2025 * |
-3.05
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.64% |
Latest transcript on Alligator Bioscience AB
1 week | +0.31% | ||
Current month | -11.89% | ||
1 month | -12.05% | ||
3 months | +39.91% | ||
6 months | +136.52% | ||
Current year | +41.94% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Dixon
BRD | Director/Board Member | 63 | 19-05-08 |
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 22-05-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.994 | +2.26% | 700 077 |
24-03-27 | 0.972 | -1.02% | 1,522,143 |
24-03-26 | 0.982 | -0.51% | 1,205,807 |
24-03-25 | 0.987 | -1.50% | 1,197,260 |
24-03-22 | 1.002 | +2.77% | 1,376,463 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 05:32 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.94% | 60.21M | |
+9.16% | 45.97B | |
+53.86% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |